{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:06:20Z","timestamp":1790042780992,"version":"4.0.1"},"reference-count":500,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003852","name":"Campania Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pharmr.2026.100153","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:05:05Z","timestamp":1784588705000},"page":"100153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kv7 channels as pharmacological targets for central nervous system diseases"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-1402","authenticated-orcid":false,"given":"Francesco","family":"Miceli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia","family":"Soldovieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-8843","authenticated-orcid":false,"given":"Vincenzo","family":"Barrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-0560","authenticated-orcid":false,"given":"Maurizio","family":"Taglialatela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2026.100153_bib1","first-page":"293","article-title":"The roles and regulation of potassium in bacteria","volume":"vol 75","author":"Epstein","year":"2003"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1134\/S0006297915050016","article-title":"Ancient systems of sodium\/potassium homeostasis as predecessors of membrane bioenergetics","volume":"80","author":"Dibrova","year":"2015","journal-title":"Biochemistry (Mosc)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev-pharmtox-010919-023755","article-title":"Neurons, receptors, and channels","volume":"60","author":"Brown","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1476-5381.1980.tb09778.x","article-title":"Intracellular observations on the effects of muscarinic agonists on rat sympathetic neurones","volume":"70","author":"Brown","year":"1980","journal-title":"Br J Pharmacol"},{"issue":"5748","key":"10.1016\/j.pharmr.2026.100153_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/283673a0","article-title":"Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone","volume":"283","author":"Brown","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100153_bib6","first-page":"161","article-title":"Chapter 12 Potassium currents in hippocampal pyramidal cells","volume":"vol 83","author":"Storm","year":"1990"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100153_bib7","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1523\/JNEUROSCI.0765-04.2004","article-title":"KCNQ\/M channels control spike afterdepolarization and burst generation in hippocampal neurons","volume":"24","author":"Yue","year":"2004","journal-title":"J Neurosci"},{"issue":"81","key":"10.1016\/j.pharmr.2026.100153_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1113\/jphysiol.1992.sp019030","article-title":"Ionic currents of outer hair cells isolated from the guinea-pig cochlea","volume":"448","author":"Housley","year":"1992","journal-title":"J Physiol"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100153_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.heares.2010.01.002","article-title":"Property of IK, n in inner hair cells isolated from guinea-pig cochlea","volume":"261","author":"Kimitsuki","year":"2010","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1152\/jn.1994.71.1.317","article-title":"Potassium currents in mammalian and avian isolated type I semicircular canal hair cells","volume":"71","author":"Rennie","year":"1994","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1152\/jn.1996.76.2.995","article-title":"A delayed rectifier conductance in type I hair cells of the mouse utricle","volume":"76","author":"R\u00fcsch","year":"1996","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1113\/jphysiol.1980.sp013509","article-title":"Behaviour of the rod network in the tiger salamander retina mediated by membrane properties of individual rods","volume":"309","author":"Attwell","year":"1980","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1113\/jphysiol.1982.sp014372","article-title":"Voltage-activated and calcium-activated currents studied in solitary rod inner segments from the salamander retina","volume":"331","author":"Bader","year":"1982","journal-title":"J Physiol"},{"issue":"6 Pt 1","key":"10.1016\/j.pharmr.2026.100153_bib14","doi-asserted-by":"crossref","first-page":"C1844","DOI":"10.1152\/ajpcell.1997.272.6.C1844","article-title":"Regulation of M-like K+ current, IKx, by Ca(2+)-dependent phosphorylation in rod photoreceptors","volume":"272","author":"Kurennyi","year":"1997","journal-title":"Am J Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1114\/1.1521415","article-title":"Modulation of rod photoreceptor potassium Kx current by divalent cations","volume":"30","author":"Kourennyi","year":"2002","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev-pharmtox-010617-052912","article-title":"KCNQ-encoded potassium channels as therapeutic targets","volume":"58","author":"Barrese","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1113\/jphysiol.1985.sp015837","article-title":"Cholinergic agonists suppress a potassium current in freshly dissociated smooth muscle cells of the toad","volume":"367","author":"Sims","year":"1985","journal-title":"J Physiol"},{"issue":"4836","key":"10.1016\/j.pharmr.2026.100153_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.2827305","article-title":"Antagonistic adrenergic-muscarinic regulation of M current in smooth muscle cells","volume":"239","author":"Sims","year":"1988","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1113\/jphysiol.1996.sp021694","article-title":"Properties of a novel K+ current that is active at resting potential in rabbit pulmonary artery smooth muscle cells","volume":"496","author":"Evans","year":"1996","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bjp.0706342","article-title":"Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells","volume":"146","author":"Yeung","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.drudis.2013.12.003","article-title":"K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders","volume":"19","author":"Stott","year":"2014","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"6208","key":"10.1016\/j.pharmr.2026.100153_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/337647a0","article-title":"Benign familial neonatal convulsions linked to genetic markers on chromosome 20","volume":"337","author":"Leppert","year":"1989","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib24","first-page":"670","article-title":"Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q","volume":"53","author":"Lewis","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"5349","key":"10.1016\/j.pharmr.2026.100153_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0198-53","article-title":"A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family","volume":"18","author":"Charlier","year":"1998","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0196-17","article-title":"Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias","volume":"12","author":"Wang","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)80556-5","article-title":"KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness","volume":"96","author":"Kubisch","year":"1999","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.pharmr.2026.100153_bib30","doi-asserted-by":"crossref","first-page":"22395","DOI":"10.1074\/jbc.M002378200","article-title":"Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity","volume":"275","author":"Lerche","year":"2000","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100153_bib31","doi-asserted-by":"crossref","first-page":"24089","DOI":"10.1074\/jbc.M003245200","article-title":"KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents","volume":"275","author":"Schroeder","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajhg.2017.05.016","article-title":"Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy","volume":"101","author":"Lehman","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100153_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116887119","article-title":"Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy","volume":"119","author":"Nappi","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5395","key":"10.1016\/j.pharmr.2026.100153_bib34","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100153_bib35","doi-asserted-by":"crossref","first-page":"19419","DOI":"10.1074\/jbc.273.31.19419","article-title":"Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy","volume":"273","author":"Yang","year":"1998","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100153_bib36","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1523\/JNEUROSCI.0882-04.2004","article-title":"Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent","volume":"24","author":"Li","year":"2004","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib37","first-page":"365","article-title":"Driving with no brakes: molecular pathophysiology of Kv7 potassium channels","volume":"26","author":"Soldovieri","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.pharmr.2026.100153_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphys.2020.00992","article-title":"Heteromeric channels formed from alternating Kv7.4 and Kv7.5 \u03b1-subunits display biophysical, regulatory, and pharmacological characteristics of smooth muscle M-currents","volume":"11","author":"Brueggemann","year":"2020","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-5793(98)01296-4","article-title":"The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3","volume":"438","author":"Tinel","year":"1998","journal-title":"FEBS Lett"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100153_bib40","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1523\/JNEUROSCI.21-24-09529.2001","article-title":"M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain","volume":"21","author":"Cooper","year":"2001","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bjp.0704989","article-title":"Antibodies and a cysteine-modifying reagent show correspondence of M current in neurons to KCNQ2 and KCNQ3 K+ channels","volume":"137","author":"Roche","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100153_bib42","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1073\/pnas.1004644107","article-title":"The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus","volume":"107","author":"Tzingounis","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib43","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1073\/pnas.090092797","article-title":"Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy","volume":"97","author":"Cooper","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1113\/jphysiol.2002.028571","article-title":"Molecular correlates of the M-current in cultured rat hippocampal neurons","volume":"544","author":"Shah","year":"2002","journal-title":"J Physiol"},{"issue":"47","key":"10.1016\/j.pharmr.2026.100153_bib45","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1523\/JNEUROSCI.3521-06.2006","article-title":"Somatodendritic Kv7\/KCNQ\/M channels control interspike interval in hippocampal interneurons","volume":"26","author":"Lawrence","year":"2006","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100153_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neulet.2006.02.017","article-title":"Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain","volume":"400","author":"Geiger","year":"2006","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1523\/JNEUROSCI.4512-03.2004","article-title":"KCNQ2 Is a nodal K+ channel","volume":"24","author":"Devaux","year":"2004","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib48","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1523\/JNEUROSCI.4314-05.2006","article-title":"A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon","volume":"26","author":"Pan","year":"2006","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1242\/jcs.03396","article-title":"Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment","volume":"120","author":"Rasmussen","year":"2007","journal-title":"J Cell Sci"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100153_bib50","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1073\/pnas.0802805105","article-title":"Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons","volume":"105","author":"Shah","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100153_bib51","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1073\/pnas.0603376103","article-title":"Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains","volume":"103","author":"Chung","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1523\/JNEUROSCI.3143-03.2004","article-title":"M Channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals","volume":"24","author":"Martire","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1471-4159.2007.04562.x","article-title":"Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes","volume":"102","author":"Martire","year":"2007","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cne.21497","article-title":"The potassium channel KCNQ5\/Kv7.5 is localized in synaptic endings of auditory brainstem nuclei of the rat","volume":"505","author":"Caminos","year":"2007","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1471-4159.2009.05945.x","article-title":"Activation of pre-synaptic M-type K+ channels inhibits [3H]d-aspartate release by reducing Ca2+ entry through P\/Q-type voltage-gated Ca2+ channels","volume":"109","author":"Luisi","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2026.100153_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s42003-019-0408-4","article-title":"The subthreshold-active KV7 current regulates neurotransmission by limiting spike-induced Ca2+ influx in hippocampal mossy fiber synaptic terminals","volume":"2","author":"Martinello","year":"2019","journal-title":"Commun Biol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100153_bib57","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1523\/JNEUROSCI.0363-20.2022","article-title":"KCNQ Channels enable reliable presynaptic spiking and synaptic transmission at high frequency","volume":"42","author":"Zhang","year":"2022","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jnr.23516","article-title":"Loss of auditory activity modifies the location of potassium channel KCNQ5 in auditory brainstem neurons","volume":"93","author":"Caminos","year":"2015","journal-title":"J Neurosci Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nn.2830","article-title":"KCNQ5 channels control resting properties and release probability of a synapse","volume":"14","author":"Huang","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.570588","article-title":"The role of Kv7.2 in neurodevelopment: insights and gaps in our understanding","volume":"11","author":"Dirkx","year":"2020","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib61","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1523\/JNEUROSCI.21-04-01096.2001","article-title":"Differential expression of KCNQ2 splice variants: implications to M Current function during neuronal development","volume":"21","author":"Smith","year":"2001","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.expneurol.2011.03.018","article-title":"Potential role of KCNQ\/M-channels in regulating neuronal differentiation in mouse hippocampal and embryonic stem cell-derived neuronal cultures","volume":"229","author":"Zhou","year":"2011","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib64","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbrc.2008.04.129","article-title":"Expression profile and characterisation of a truncated KCNQ5 splice variant","volume":"371","author":"Yeung","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"40","key":"10.1016\/j.pharmr.2026.100153_bib65","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1523\/JNEUROSCI.2110-05.2005","article-title":"Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-frequency hearing loss","volume":"25","author":"Beisel","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.12.087","article-title":"Developmental expression of Kcnq4 in vestibular neurons and neurosensory epithelia","volume":"1139","author":"Rocha-Sanchez","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib67","author":"Institute"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib68","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.braindev.2007.11.003","article-title":"Developmental changes in KCNQ2 and KCNQ3 expression in human brain: possible contribution to the age-dependent etiology of benign familial neonatal convulsions","volume":"30","author":"Kanaumi","year":"2008","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.01.023","article-title":"Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain","volume":"1077","author":"Weber","year":"2006","journal-title":"Brain Res"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100153_bib70","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1113\/jphysiol.2008.156257","article-title":"Low expression of Kv7\/M channels facilitates intrinsic and network bursting in the developing rat hippocampus","volume":"586","author":"Safiulina","year":"2008","journal-title":"J Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00424-018-2155-7","article-title":"Kv7 channels are upregulated during striatal neuron development and promote maturation of human iPSC-derived neurons","volume":"470","author":"Telezhkin","year":"2018","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00018-016-2359-y","article-title":"Modulation of Kv7 channels and excitability in the brain","volume":"74","author":"Greene","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100153_bib73","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1523\/JNEUROSCI.22-18-07991.2002","article-title":"Calmodulin is an auxiliary subunit of KCNQ2\/3 potassium channels","volume":"22","author":"Wen","year":"2002","journal-title":"J Neurosci"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100153_bib74","doi-asserted-by":"crossref","first-page":"28545","DOI":"10.1074\/jbc.M204130200","article-title":"The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels","volume":"277","author":"Yus-N\u00e1jera","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0306-4522(03)00321-X","article-title":"Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation","volume":"120","author":"Yus-n\u00e1jera","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2026.100153_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107296","article-title":"Persistent Kv7.2\/7.3 downregulation in the rat pilocarpine model of mesial temporal lobe epilepsy","volume":"200","author":"M\u00fcller","year":"2024","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib77","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cvr\/cvab031","article-title":"Impaired Kv7 channel activity in the central amygdala contributes to elevated sympathetic outflow in hypertension","volume":"118","author":"Sheng","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib78","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/cvr\/cvad056","article-title":"Corticotropin-releasing hormone neurons in the central nucleus of amygdala are required for chronic stress-induced hypertension","volume":"119","author":"Sheng","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"6583","key":"10.1016\/j.pharmr.2026.100153_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh3021","article-title":"Hyperexcitable arousal circuits drive sleep instability during aging","volume":"375","author":"Li","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100153_bib80","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91663","article-title":"Sympathetic motor neuron dysfunction is a missing link in age-associated sympathetic overactivity","volume":"12","author":"de La Cruz","year":"2024","journal-title":"eLife"},{"issue":"40","key":"10.1016\/j.pharmr.2026.100153_bib81","doi-asserted-by":"crossref","first-page":"13235","DOI":"10.1523\/JNEUROSCI.1981-10.2010","article-title":"Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability","volume":"30","author":"Mucha","year":"2010","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib82","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.pain.2010.12.028","article-title":"Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury","volume":"152","author":"Rose","year":"2011","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1091\/mbc.e11-12-1044","article-title":"Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels","volume":"24","author":"Iannotti","year":"2013","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib84","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12964-024-01797-2","article-title":"Involvement of HDAC2-mediated kcnq2\/kcnq3 genes transcription repression activated by EREG\/EGFR-ERK-Runx1 signaling in bone cancer pain. Cell","volume":"22","author":"Zhang","year":"2024","journal-title":"Commun Signal"},{"key":"10.1016\/j.pharmr.2026.100153_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2025.105511","article-title":"DNMT. DNMT3a contributes to bone cancer pain by epigenetic silencing of Kcnq2\/Kcnq3 in dorsal root ganglion neurons","volume":"35","author":"Zhang","year":"2025","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib86","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.neuron.2012.10.019","article-title":"Activity-dependent transcriptional regulation of M-type (Kv7) K+ channels by AKAP79\/150-mediated NFAT actions","volume":"76","author":"Zhang","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100153_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.838419","article-title":"Homeostatic regulation of extracellular signal-regulated kinase 1\/2 activity and axonal Kv7.3 expression by prolonged blockade of hippocampal neuronal activity","volume":"16","author":"Baculis","year":"2022","journal-title":"Front Cell Neurosci"},{"issue":"47","key":"10.1016\/j.pharmr.2026.100153_bib88","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110200118","article-title":"Posttranscriptional modulation of KCNQ2 gene expression by the miR-106b microRNA family","volume":"118","author":"Kim","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100153_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2025.105472","article-title":"miR-106b-5p downregulate KCNQ2 expression contributing to incisional pain in male rats","volume":"34","author":"Zhou","year":"2025","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib90","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/jcb.24771","article-title":"190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K+ channel in arterial smooth muscle cells","volume":"115","author":"Li","year":"2014","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvw177","article-title":"MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension","volume":"112","author":"Carr","year":"2016","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12576-021-00814-0","article-title":"miR-153\/KCNQ4 axis contributes to noise-induced hearing loss in a mouse model","volume":"71","author":"Wang","year":"2021","journal-title":"J Physiol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib93","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1096\/fj.07-9712com","article-title":"Calmodulin regulates the trafficking of KCNQ2 potassium channels","volume":"22","author":"Etxeberria","year":"2008","journal-title":"FASEB J"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100153_bib94","doi-asserted-by":"crossref","first-page":"20668","DOI":"10.1074\/jbc.M109.019539","article-title":"Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum","volume":"284","author":"Alaimo","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1242\/jcs.114082","article-title":"Cooperativity between calmodulin-binding sites in Kv7.2 channels","volume":"126","author":"Alaimo","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmr.2026.100153_bib96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mcn.2013.12.005","article-title":"Calmodulin orchestrates the heteromeric assembly and the trafficking of KCNQ2\/3 (Kv7.2\/3) channels in neurons","volume":"58","author":"Liu","year":"2014","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103655","article-title":"Polarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit","volume":"9","author":"Cavaretta","year":"2014","journal-title":"PLOS One"},{"issue":"27","key":"10.1016\/j.pharmr.2026.100153_bib98","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1074\/jbc.M115.638932","article-title":"An ankyrin-G N-terminal gate and protein kinase CK2 dually regulate binding of voltage-gated sodium and KCNQ2\/3 potassium channels","volume":"290","author":"Xu","year":"2015","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib99","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1523\/JNEUROSCI.2631-15.2016","article-title":"Live imaging of Kv7.2\/7.3 cell surface dynamics at the axon initial segment: high steady-state stability and calpain-dependent excitotoxic downregulation revealed","volume":"36","author":"Benned-Jensen","year":"2016","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib100","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1038\/s41467-023-39203-z","article-title":"Kv7\/KCNQ potassium channels in cortical hyperexcitability and juvenile seizure-related death in Ank2-mutant mice","volume":"14","author":"Oh","year":"2023","journal-title":"Nat Commun"},{"issue":"47","key":"10.1016\/j.pharmr.2026.100153_bib101","doi-asserted-by":"crossref","first-page":"E10234","DOI":"10.1073\/pnas.1708700114","article-title":"M-current inhibition rapidly induces a unique CK2-dependent plasticity of the axon initial segment","volume":"114","author":"Lezmy","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100153_bib102","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1523\/JNEUROSCI.1914-19.2020","article-title":"M-current inhibition in hippocampal excitatory neurons triggers intrinsic and synaptic homeostatic responses at different temporal scales","volume":"40","author":"Lezmy","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.972023","article-title":"Excitatory and inhibitory hippocampal neurons differ in their homeostatic adaptation to chronic M-channel modulation","volume":"15","author":"Bar","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib104","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1093\/brain\/awaf243","article-title":"Endosomal 2Cl\u2212\/H+ exchangers regulate neuronal excitability by tuning Kv7\/KCNQ channel density","volume":"148","author":"Qi","year":"2025","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00018-024-05312-1","article-title":"A versatile functional interaction between electrically silent KV subunits and KV7 potassium channels","volume":"81","author":"Renigunta","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib106","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn1785","article-title":"Pathways modulating neural KCNQ\/M (Kv7) potassium channels","volume":"6","author":"Delmas","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101183","article-title":"The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels","volume":"297","author":"Chen","year":"2021","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib108","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/hsz-2023-0204","article-title":"Crosstalk between cholesterol and PIP2 in the regulation of Kv7.2\/Kv7.3 channels","volume":"405","author":"Delgado-Ram\u00edrez","year":"2024","journal-title":"Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1113\/JP273274","article-title":"Phosphorylation regulates the sensitivity of voltage-gated Kv7.2 channels towards phosphatidylinositol-4,5-bisphosphate","volume":"595","author":"Salzer","year":"2017","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00424-016-1916-4","article-title":"Synergistic interplay of G\u03b2\u03b3 and phosphatidylinositol 4,5-bisphosphate dictates Kv7.4 channel activity","volume":"469","author":"Povstyan","year":"2017","journal-title":"Pflugers Arch - Eur J Physiol"},{"issue":"43","key":"10.1016\/j.pharmr.2026.100153_bib111","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1523\/JNEUROSCI.2597-05.2005","article-title":"Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate","volume":"25","author":"Li","year":"2005","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib112","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1113\/jphysiol.2007.132498","article-title":"Regulation of M(Kv7.2\/7.3) channels in neurons by PIP2 and products of PIP2 hydrolysis: significance for receptor-mediated inhibition","volume":"582","author":"Brown","year":"2007","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib113","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bpj.2016.01.006","article-title":"The voltage activation of cortical KCNQ channels depends on global PIP2 levels","volume":"110","author":"Kim","year":"2016","journal-title":"Biophys J"},{"key":"10.1016\/j.pharmr.2026.100153_bib114","series-title":"Ion Channels in Biophysics and Physiology","first-page":"335","article-title":"Physiological functions, biophysical properties, and regulation of KCNQ1 (KV7.1) potassium channels","author":"Sanguinetti","year":"2021"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100153_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(00)01918-9","article-title":"M-type KCNQ2\u2013KCNQ3 potassium channels are modulated by the KCNE2 subunit","volume":"480","author":"Tinel","year":"2000","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib116","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bpj.2017.06.055","article-title":"SMIT1 modifies KCNQ channel function and pharmacology by physical interaction with the pore","volume":"113","author":"Manville","year":"2017","journal-title":"Biophys J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/apha.12663","article-title":"Polyunsaturated fatty acids are potent openers of human M-channels expressed in Xenopus laevis oocytes","volume":"218","author":"Liin","year":"2016","journal-title":"Acta Physiol (Oxf)"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100153_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095158","article-title":"Functional coassembly of KCNQ4 with KCNE-\u00df- subunits in Xenopus oocytes","volume":"18","author":"Strutz-Seebohm","year":"2006","journal-title":"Cell Physiol Biochem"},{"issue":"5\u20136","key":"10.1016\/j.pharmr.2026.100153_bib119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000257425","article-title":"Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel","volume":"24","author":"Roura-Ferrer","year":"2009","journal-title":"Cell Physiol Biochem"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100153_bib120","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1113\/JP271286","article-title":"Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone","volume":"593","author":"Jepps","year":"2015","journal-title":"J Physiol"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100153_bib121","article-title":"Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510)","volume":"6","author":"de Jong","year":"2018","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1085\/jgp.200208783","article-title":"Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels","volume":"122","author":"Gamper","year":"2003","journal-title":"J Gen Physiol"},{"issue":"45","key":"10.1016\/j.pharmr.2026.100153_bib123","doi-asserted-by":"crossref","first-page":"16454","DOI":"10.1073\/pnas.0503966102","article-title":"Expression of a calmodulin-binding KCNQ2 potassium channel fragment modulates neuronal M-current and membrane excitability","volume":"102","author":"Shahidullah","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025508","article-title":"Kv7 channels can function without constitutive calmodulin tethering","volume":"6","author":"G\u00f3mez-Posada","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib125","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1113\/jphysiol.2008.152777","article-title":"Calmodulin binding to M-type K+ channels assayed by TIRF\/FRET in living cells","volume":"586","author":"Bal","year":"2008","journal-title":"J Physiol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib126","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1091\/mbc.e04-09-0849","article-title":"Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+\/calmodulin","volume":"16","author":"Gamper","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib127","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000218979.40770.69","article-title":"Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations","volume":"98","author":"Shamgar","year":"2006","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0896-6273(00)80032-X","article-title":"Intracellular calcium directly inhibits potassium M Channels in excised membrane patches from rat sympathetic neurons","volume":"16","author":"Selyanko","year":"1996","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0896-6273(91)90056-6","article-title":"Modulation of M-current by intracellular Ca2+","volume":"6","author":"Marrion","year":"1991","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib130","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bbadis.2015.06.012","article-title":"Epilepsy-causing mutations in Kv7.2 C-terminus affect binding and functional modulation by calmodulin","volume":"1852","author":"Ambrosino","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2026.100153_bib131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fnmol.2017.00117","article-title":"Differential regulation of PI(4,5)P2 sensitivity of Kv7.2 and Kv7.3 channels by calmodulin","volume":"10","author":"Gomis-Perez","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13811-4","article-title":"Calmodulin confers calcium sensitivity to the stability of the distal intracellular assembly domain of Kv7.2 channels","volume":"7","author":"Alaimo","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082290","article-title":"A change in configuration of the calmodulin-KCNQ channel complex underlies Ca2+-dependent modulation of KCNQ channel activity","volume":"8","author":"Kosenko","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib134","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.1800235115","article-title":"Structural basis and energy landscape for the Ca2+ gating and calmodulation of the Kv7.2 K+ channel","volume":"115","author":"Bernardo-Seisdedos","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuron.2018.01.035","article-title":"A calmodulin C-lobe Ca2+-dependent switch governs Kv7 channel function","volume":"97","author":"Chang","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib136","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1523\/JNEUROSCI.5175-09.2010","article-title":"Ca2+\/calmodulin disrupts AKAP79\/150 interactions with KCNQ (M-type) K+ channels","volume":"30","author":"Bal","year":"2010","journal-title":"J Neurosci"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100153_bib137","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1242\/jcs.176420","article-title":"Uncoupling PIP2-calmodulin regulation of Kv7.2 channels by an assembly destabilizing epileptogenic mutation","volume":"128","author":"Alberdi","year":"2015","journal-title":"J Cell Sci"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100153_bib138","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1074\/jbc.M113.528497","article-title":"Channel-anchored protein kinase CK2 and protein phosphatase 1 reciprocally regulate KCNQ2-containing M-channels via phosphorylation of calmodulin","volume":"289","author":"Kang","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib139","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81961","article-title":"Redox regulation of KV7 channels through EF3 hand of calmodulin","volume":"12","author":"Nu\u00f1ez","year":"2023","journal-title":"eLife"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100153_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700015","article-title":"Updating in vivo and in vitro phosphorylation and methylation sites of voltage-gated Kv7.2 potassium channels","volume":"17","author":"Erdem","year":"2017","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib141","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nn1062","article-title":"AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists","volume":"6","author":"Hoshi","year":"2003","journal-title":"Nat Neurosci"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100153_bib142","doi-asserted-by":"crossref","first-page":"45399","DOI":"10.1074\/jbc.M408410200","article-title":"Dual phosphorylations underlie modulation of unitary KCNQ K+ channels by Src tyrosine kinase","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib143","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2911-06.2007","article-title":"Activation of epidermal growth factor receptor inhibits KCNQ2\/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation","volume":"27","author":"Jia","year":"2007","journal-title":"J Neurosci"},{"issue":"6712","key":"10.1016\/j.pharmr.2026.100153_bib144","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/25367","article-title":"Moderate loss of function of cyclic-AMP-modulated KCNQ2\/KCNQ3 K+ channels causes epilepsy","volume":"396","author":"Schroeder","year":"1998","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100153_bib145","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1111\/bph.16349","article-title":"Calcium-sensing receptor regulates Kv7 channels via Gi\/o protein signalling and modulates excitability of human induced pluripotent stem cell-derived nociceptive-like neurons","volume":"181","author":"Chuinsiri","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib146","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1038\/emboj.2012.156","article-title":"Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation","volume":"31","author":"Kosenko","year":"2012","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib147","doi-asserted-by":"crossref","first-page":"C73","DOI":"10.1152\/ajpcell.00146.2008","article-title":"Regulation of the voltage-gated K+ channels KCNQ2\/3 and KCNQ3\/5 by serum- and glucocorticoid-regulated kinase-1","volume":"295","author":"Schuetz","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib148","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1523\/JNEUROSCI.3442-12.2013","article-title":"The neuronal serum- and glucocorticoid-regulated kinase 1.1 reduces neuronal excitability and protects against seizures through upregulation of the M-current","volume":"33","author":"Miranda","year":"2013","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006586","article-title":"Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity","volume":"4","author":"Regev","year":"2009","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.pharmr.2026.100153_bib150","doi-asserted-by":"crossref","first-page":"14158","DOI":"10.1523\/JNEUROSCI.2666-11.2011","article-title":"Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A","volume":"31","author":"Etzioni","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib151","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/humu.22500","article-title":"Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by Syntaxin-1A","volume":"35","author":"Soldovieri","year":"2014","journal-title":"Hum Mutat"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100153_bib152","doi-asserted-by":"crossref","first-page":"E3290","DOI":"10.1073\/pnas.1606348113","article-title":"Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P 2 levels","volume":"113","author":"Dai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib153","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/ATVBAHA.120.315096","article-title":"SMIT (sodium-myo-inositol transporter) 1 regulates arterial contractility through the modulation of vascular Kv7 channels","volume":"40","author":"Barrese","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"45","key":"10.1016\/j.pharmr.2026.100153_bib154","doi-asserted-by":"crossref","first-page":"18577","DOI":"10.1073\/pnas.1209142109","article-title":"Modulation of voltage-gated K+ channels by the sodium channel \u03b21 subunit","volume":"109","author":"Nguyen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib155","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1523\/JNEUROSCI.3127-14.2015","article-title":"\u03b2-secretase BACE1 Regulates hippocampal and Reconstituted M-Currents in a \u03b2-Subunit-Like Fashion","volume":"35","author":"Hessler","year":"2015","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib156","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202112888","article-title":"Neuronal KCNQ2\/3 channels are recruited to lipid raft microdomains by palmitoylation of BACE1","volume":"154","author":"Dai","year":"2022","journal-title":"J Gen Physiol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100153_bib157","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1073\/pnas.1418605112","article-title":"G-protein \u03b2\u03b3 subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity","volume":"112","author":"Stott","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100153_bib158","doi-asserted-by":"crossref","first-page":"E2472","DOI":"10.1073\/pnas.1406728111","article-title":"The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels","volume":"111","author":"Iannotti","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100153_bib159","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fphys.2020.00641","article-title":"Polyunsaturated fatty acids as modulators of KV7 channels","volume":"11","author":"Larsson","year":"2020","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib160","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202012576","article-title":"Combining endocannabinoids with retigabine for enhanced M-channel effect and improved KV7 subtype selectivity","volume":"152","author":"Larsson","year":"2020","journal-title":"J Gen Physiol"},{"issue":"43","key":"10.1016\/j.pharmr.2026.100153_bib161","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1523\/JNEUROSCI.2307-22.2023","article-title":"Dehydroepiandrosterone sulfate (DHEAS) is an endogenous Kv7 channel modulator that reduces Kv7\/M-current suppression and inflammatory pain","volume":"43","author":"Alhassen","year":"2023","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib162","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.119.263350","article-title":"M-channel activation contributes to the anticonvulsant action of the ketone body \u03b2-hydroxybutyrate","volume":"372","author":"Manville","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib163","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3389\/fphys.2020.01040","article-title":"A novel Kv7.3 variant in the voltage-sensing S4 segment in a family with benign neonatal epilepsy: functional characterization and in vitro rescue by \u03b2-hydroxybutyrate","volume":"11","author":"Miceli","year":"2020","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib164","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.neuron.2014.07.042","article-title":"Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death","volume":"83","author":"Qi","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib165","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1038\/s41467-023-42416-x","article-title":"Ligand activation mechanisms of human KCNQ2 channel","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib166","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-023-37531-8","article-title":"Central cavity dehydration as a gating mechanism of potassium channels","volume":"14","author":"Gu","year":"2023","journal-title":"Nat Commun"},{"issue":"50","key":"10.1016\/j.pharmr.2026.100153_bib167","doi-asserted-by":"crossref","first-page":"20093","DOI":"10.1073\/pnas.1312483110","article-title":"Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100153_bib168","doi-asserted-by":"crossref","first-page":"E2399","DOI":"10.1073\/pnas.1207901109","article-title":"PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4-S5 linker","volume":"109","author":"Rodriguez-Menchaca","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib169","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00424-012-1199-3","article-title":"A basic residue in the proximal C-terminus is necessary for efficient activation of the M-channel subunit Kv7.2 by PI(4,5)P2","volume":"465","author":"Telezhkin","year":"2013","journal-title":"Pflugers Arch"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100153_bib170","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.1305167110","article-title":"Kv7.1 ion channels require a lipid to couple voltage sensing to pore opening","volume":"110","author":"Zaydman","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"45","key":"10.1016\/j.pharmr.2026.100153_bib171","doi-asserted-by":"crossref","first-page":"E9702","DOI":"10.1073\/pnas.1705802114","article-title":"PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels","volume":"114","author":"Kim","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib172","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s42003-021-02729-3","article-title":"PIP2-dependent coupling of voltage sensor and pore domains in Kv7.2 channel","volume":"4","author":"Pant","year":"2021","journal-title":"Commun Biol"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib173","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416738122","article-title":"Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5","volume":"122","author":"Yang","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100153_bib174","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1074\/jbc.M609385200","article-title":"Regulation of the voltage-gated K+ channels KCNQ2\/3 and KCNQ3\/5 by ubiquitination","volume":"282","author":"Ekberg","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib175","first-page":"274","article-title":"Gating currents from neuronal K(V)7.4 channels: general features and correlation with the ionic conductance","volume":"34","author":"Miceli","year":"2009","journal-title":"Channels (Austin)"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib176","doi-asserted-by":"crossref","first-page":"E559","DOI":"10.1073\/pnas.1222616110","article-title":"IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits","volume":"110","author":"Ruscic","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib177","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41467-020-14406-w","article-title":"Two-stage electro-mechanical coupling of a Kv channel in voltage-dependent activation","volume":"11","author":"Hou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100153_bib178","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77030","article-title":"Distinctive mechanisms of epilepsy-causing mutants discovered by measuring S4 movement in KCNQ2 channels","volume":"11","author":"Edmond","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib179","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41467-026-69249-8","article-title":"Two-step voltage-sensor activation of the human KV7.4 channel and effect of a deafness-associated mutation","volume":"17","author":"Nappi","year":"2026","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100153_bib180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301985120","article-title":"The membrane electric field regulates the PIP2-binding site to gate the KCNQ1 channel","volume":"120","author":"Mandala","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib181","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41422-020-00410-8","article-title":"Molecular basis for ligand activation of the human KCNQ2 channel","volume":"31","author":"Li","year":"2021","journal-title":"Cell Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib182","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41589-024-01834-8","article-title":"Small molecule inhibits KCNQ channels with a non-blocking mechanism","volume":"21","author":"Li","year":"2025","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib183","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41589-023-01515-y","article-title":"A small-molecule activation mechanism that directly opens the KCNQ2 channel","volume":"20","author":"Zhang","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116771","article-title":"Structure basis for the activation of KCNQ2 by endogenous and exogenous ligands","volume":"45","author":"Zhao","year":"2025","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2020.10.037","article-title":"Structural basis for the modulation of human KCNQ4 by small-molecule drugs","volume":"81","author":"Li","year":"2021","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib186","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2021.10.029","article-title":"Structural insights into the lipid and ligand regulation of a human neuronal KCNQ channel","volume":"110","author":"Zheng","year":"2022","journal-title":"Neuron"},{"issue":"5974","key":"10.1016\/j.pharmr.2026.100153_bib187","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.1185954","article-title":"A gating charge transfer center in voltage sensors","volume":"328","author":"Tao","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib188","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1523\/JNEUROSCI.4423-14.2015","article-title":"Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits","volume":"35","author":"Miceli","year":"2015","journal-title":"J Neurosci"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib189","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/ijms20143382","article-title":"Epileptic encephalopathy in A patient with A novel variant in the Kv7.2 S2 transmembrane segment: clinical, genetic, and functional features","volume":"20","author":"Soldovieri","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2024.100011","article-title":"Voltage sensors","volume":"107","author":"Jan","year":"2025","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib191","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0896-6273(02)00790-0","article-title":"Recovery from muscarinic modulation of M Current channels requires phosphatidylinositol 4,5-bisphosphate synthesis","volume":"35","author":"Suh","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100153_bib192","series-title":"GeneReviews\u00ae","article-title":"KCNQ2-related disorders","author":"Miceli","year":"1993"},{"key":"10.1016\/j.pharmr.2026.100153_bib193","series-title":"Atlas of Epilepsies","first-page":"835","article-title":"Benign Familial Neonatal Seizures","author":"Plouin","year":"2010"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib194","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00424-020-02404-2","article-title":"Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction","volume":"472","author":"Nappi","year":"2020","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmr.2026.100153_bib195","series-title":"3eds. Epilepsy: A Comprehensive Textbook","article-title":"Chapter 275","author":"Pressler","year":"2023"},{"key":"10.1016\/j.pharmr.2026.100153_bib196","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.seizure.2018.05.005","article-title":"Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy","volume":"59","author":"Kothur","year":"2018","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib197","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/epi4.12353","article-title":"A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy","volume":"4","author":"Lauritano","year":"2019","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib198","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.22644","article-title":"KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy","volume":"71","author":"Weckhuysen","year":"2012","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib199","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/epi.12200","article-title":"Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation","volume":"54","author":"Kato","year":"2013","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib200","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/ajmg.a.37152","article-title":"Variable clinical expression in patients with mosaicism for KCNQ2 mutations","volume":"167A","author":"Milh","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pharmr.2026.100153_bib201","series-title":"GeneReviews\u00ae","article-title":"KCNQ3-related disorders","author":"Miceli","year":"1993"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1152\/jn.00509.2021","article-title":"Human KCNQ5 de novo mutations underlie epilepsy and intellectual disability","volume":"128","author":"Wei","year":"2022","journal-title":"J Neurophysiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2018.10.007","article-title":"Intragenic duplication of KCNQ5 gene results in aberrant splicing leading to a premature termination codon in a patient with intellectual disability","volume":"62","author":"Rosti","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib204","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0166-2236(91)90003-D","article-title":"GABA: an excitatory transmitter in early postnatal life","volume":"14","author":"Cherubini","year":"1991","journal-title":"Trends Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100153_bib205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(02)00249-8","article-title":"Age-dependent modulation of hippocampal excitability by KCNQ-channels","volume":"53","author":"Okada","year":"2003","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib207","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000096","article-title":"KCNQ2 encephalopathy: features, mutational hot spots, and ezogabine treatment of 11 patients","volume":"2","author":"Millichap","year":"2016","journal-title":"Neurol Genet"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib208","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/epi.16314","article-title":"Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy","volume":"60","author":"Goto","year":"2019","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100153_bib209","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jmb.2014.05.016","article-title":"The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability","volume":"426","author":"Villarroel","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100153_bib210","doi-asserted-by":"crossref","DOI":"10.1038\/srep38167","article-title":"Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate","volume":"6","author":"Soldovieri","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib211","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/brain\/awg286","article-title":"KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum","volume":"126","author":"Singh","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib212","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.22-02-j0003.2002","article-title":"Benign familial neonatal convulsions caused by altered gating of KCNQ2\/KCNQ3 potassium channels","volume":"22","author":"Castaldo","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2018.07.004","article-title":"Reduced axonal surface expression and phosphoinositide sensitivity in Kv7 channels disrupts their function to inhibit neuronal excitability in Kcnq2 epileptic encephalopathy","volume":"118","author":"Kim","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib214","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrm4063","article-title":"Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes","volume":"16","author":"Lykke-Andersen","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1074\/jbc.M510980200","article-title":"Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions","volume":"281","author":"Soldovieri","year":"2006","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib216","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.1216867110","article-title":"Genotype\u2013phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7.2 potassium channel subunits","volume":"110","author":"Miceli","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib217","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.24080","article-title":"Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy","volume":"75","author":"Orhan","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmr.2026.100153_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104130","article-title":"KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism","volume":"81","author":"Miceli","year":"2022","journal-title":"EBiomedicine"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib219","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/epi.13366","article-title":"A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7\/M channel activity","volume":"57","author":"Devaux","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.006","article-title":"Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment","volume":"21","author":"Bayat","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"49","key":"10.1016\/j.pharmr.2026.100153_bib221","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2412388121","article-title":"Constitutive opening of the Kv7.2 pore activation gate causes KCNQ2-developmental encephalopathy","volume":"121","author":"Nappi","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib222","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/epi.12887","article-title":"A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability","volume":"56","author":"Miceli","year":"2015","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib223","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25522","article-title":"Autism and developmental disability caused by KCNQ3 gain-of-function variants","volume":"86","author":"Sands","year":"2019","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib224","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/epi.13676","article-title":"Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H","volume":"58","author":"Mulkey","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1073858418763752","article-title":"Potassium channel gain of function in epilepsy: an unresolved paradox","volume":"24","author":"Niday","year":"2018","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib226","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1152\/jn.00205.2006","article-title":"Contribution of persistent Na+ current and M-type K+ current to somatic bursting in CA1 pyramidal cells: combined experimental and modeling study","volume":"96","author":"Golomb","year":"2006","journal-title":"J Neurophysiol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib227","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000738","article-title":"The M-current works in tandem with the persistent sodium current to set the speed of locomotion","volume":"18","author":"Verneuil","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmr.2026.100153_bib228","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","article-title":"Potassium channels in genetic epilepsy: a functional perspective","author":"Weston","year":"2024"},{"key":"10.1016\/j.pharmr.2026.100153_bib229","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64434","article-title":"Dyshomeostatic modulation of Ca2+-activated K+ channels in a human neuronal model of KCNQ2 encephalopathy","volume":"10","author":"Simkin","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2026.100153_bib230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cophys.2017.12.007","article-title":"Dravet syndrome: a sodium channel Interneuronopathy","volume":"2","author":"Catterall","year":"2018","journal-title":"Curr Opin Physiol"},{"issue":"38","key":"10.1016\/j.pharmr.2026.100153_bib231","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1523\/JNEUROSCI.0980-23.2023","article-title":"KCNQ2\/3 Gain-of-function variants and cell excitability: differential effects in CA1 versus L2\/3 pyramidal neurons","volume":"43","author":"Varghese","year":"2023","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib232","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/brain\/awab219","article-title":"KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum","volume":"144","author":"Bonardi","year":"2021","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib233","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.2441","article-title":"De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy","volume":"44","author":"Barcia","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmr.2026.100153_bib234","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92915.4","article-title":"Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons","volume":"13","author":"Shore","year":"2024","journal-title":"eLife"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib235","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/14737175.2013.857604","article-title":"Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies","volume":"13","author":"Coan","year":"2013","journal-title":"Expert Rev Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib236","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hipo.23587","article-title":"Impacted spike frequency adaptation associated with reduction of KCNQ2\/3 exacerbates seizure activity in temporal lobe epilepsy","volume":"34","author":"Jiang","year":"2024","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmr.2026.100153_bib237","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neubiorev.2017.10.016","article-title":"Behavioral changes in models of chemoconvulsant-induced epilepsy: a review","volume":"83","author":"Minjarez","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmr.2026.100153_bib238","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neubiorev.2021.08.020","article-title":"The pilocarpine model of mesial temporal lobe epilepsy: over one decade later, with more rodent species and new investigative approaches","volume":"130","author":"L\u00e9vesque","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib239","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1152\/physrev.00040.2019","article-title":"Cellular circuits in the brain and their modulation in acute and chronic pain","volume":"101","author":"Kuner","year":"2021","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib241","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41583-022-00673-7","article-title":"Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors","volume":"24","author":"Ovsepian","year":"2023","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib242","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/bph.13978","article-title":"M-type K+ channels in peripheral nociceptive pathways","volume":"175","author":"Du","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100153_bib243","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib244","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.pain.2014.08.025","article-title":"Control of somatic membrane potential in nociceptive neurons and its implications for peripheral nociceptive transmission","volume":"155","author":"Du","year":"2014","journal-title":"Pain"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100153_bib245","doi-asserted-by":"crossref","first-page":"11240","DOI":"10.1523\/JNEUROSCI.2297-08.2008","article-title":"Inhibition of M Current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception","volume":"28","author":"Linley","year":"2008","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100153_bib246","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.3390\/ijms20184322","article-title":"Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons","volume":"20","author":"Ambrosino","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5\u20136","key":"10.1016\/j.pharmr.2026.100153_bib247","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000496422","article-title":"Suppression of KCNQ\/M potassium channel in dorsal root ganglia neurons contributes to the development of osteoarthritic pain","volume":"103","author":"Zhang","year":"2019","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib248","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pain.2012.12.005","article-title":"Suppression of KCNQ\/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model","volume":"154","author":"Zheng","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib249","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917724715","article-title":"Orofacial neuropathic pain induced by oxaliplatin: downregulation of KCNQ2 channels in V2 trigeminal ganglion neurons and treatment by the KCNQ2 channel potentiator retigabine","volume":"13","author":"Ling","year":"2017","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135277","article-title":"Changes in expression of Kv7.5 and Kv7.2 channels in dorsal root ganglion neurons in the streptozotocin rat model of painful diabetic neuropathy","volume":"736","author":"Djouhri","year":"2020","journal-title":"Neurosci Lett"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib251","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/cne.23595","article-title":"Kv7.2 regulates the function of peripheral sensory neurons","volume":"522","author":"King","year":"2014","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib252","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab212","article-title":"KCNQ variants and pain modulation: a missense variant in Kv7.3 contributes to pain resilience","volume":"3","author":"Yuan","year":"2021","journal-title":"Brain Commun"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib253","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/j.pain.0000000000003479","article-title":"Trpv1-lineage neuron-expressing Kcnq4 channel modulates itch sensation in mice","volume":"166","author":"Wang","year":"2024","journal-title":"Pain"},{"issue":"7\u20138","key":"10.1016\/j.pharmr.2026.100153_bib254","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000505934","article-title":"Antinociceptive efficacy of retigabine and flupirtine for gout arthritis pain","volume":"105","author":"Zhang","year":"2020","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib255","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3892\/or.2015.3718","article-title":"Suppression of KCNQ\/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain","volume":"33","author":"Cai","year":"2015","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib256","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpain.2018.11.001","article-title":"Activation of KCNQ channels prevents paclitaxel-induced peripheral neuropathy and associated neuropathic pain","volume":"20","author":"Li","year":"2019","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib257","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/neu.2016.4789","article-title":"Activation of KCNQ channels suppresses spontaneous activity in dorsal root ganglion neurons and reduces chronic pain after spinal cord injury","volume":"34","author":"Wu","year":"2017","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.pharmr.2026.100153_bib258","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917709371","article-title":"Peripheral KV7 channels regulate visceral sensory function in mouse and human colon","volume":"13","author":"Peiris","year":"2017","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115821","article-title":"Development of KVO treatment strategies for chronic pain in a rat model of Gulf War Illness","volume":"434","author":"Flunker","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib260","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/aps.2016.33","article-title":"Activation of neuronal Kv7\/KCNQ\/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents","volume":"37","author":"Teng","year":"2016","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib261","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.120.000357","article-title":"Activation of neuronal voltage-gated potassium Kv7\/KCNQ\/M-current by a novel channel opener SCR2682 for alleviation of chronic pain","volume":"377","author":"Wang","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib262","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12990-015-0048-8","article-title":"KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia","volume":"11","author":"Abd-Elsayed","year":"2015","journal-title":"Mol Pain"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib263","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jnc.13511","article-title":"Effects of cold temperatures on the excitability of rat trigeminal ganglion neurons that are not for cold sensing","volume":"141","author":"Kanda","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2026.100153_bib264","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1416148","article-title":"Disease-modifying rdHSV-CA8\u2217 non-opioid analgesic gene therapy treats chronic osteoarthritis pain by activating Kv7 voltage-gated potassium channels","volume":"17","author":"Zhuang","year":"2024","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib265","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1476-5381.2011.01483.x","article-title":"Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels","volume":"164","author":"Du","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib266","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/j.pain.0000000000000122","article-title":"Activation of peripheral KCNQ channels relieves gout pain","volume":"156","author":"Zheng","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib267","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-10-15","article-title":"Activation of peripheral KCNQ channels attenuates inflammatory pain","volume":"10","author":"Hayashi","year":"2014","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib268","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1744-8069-7-84","article-title":"Visceral hyperalgesia induced by forebrain-specific suppression of native Kv7\/KCNQ\/M-current in mice","volume":"7","author":"Bi","year":"2011","journal-title":"Mol Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109994","article-title":"Selective inhibition of A-fiber-mediated excitatory transmission underlies the analgesic effects of KCNQ channel opening in the spinal dorsal horn","volume":"254","author":"Oyama","year":"2024","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib270","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12264-021-00668-x","article-title":"KCNQ channels in the mesolimbic reward circuit regulate nociception in chronic pain in mice","volume":"37","author":"Wang","year":"2021","journal-title":"Neurosci Bull"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib271","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1111\/bph.13113","article-title":"Thalamic Kv7 channels: pharmacological properties and activity control during noxious signal processing","volume":"172","author":"Cerina","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib272","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/s41598-018-38393-7","article-title":"Downregulation of M-channels in lateral habenula mediates hyperalgesia during alcohol withdrawal in rats","volume":"9","author":"Kang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100153_bib273","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2014.01.017","article-title":"Kv7 channels as targets for anti-epileptic and psychiatric drug-development","volume":"726","author":"Grunnet","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib274","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.97.8.4333","article-title":"KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway","volume":"97","author":"Kharkovets","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib275","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.106.106757","article-title":"The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat","volume":"318","author":"Hansen","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib276","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1113\/jphysiol.2007.149450","article-title":"Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS","volume":"586","author":"Hansen","year":"2008","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib277","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tins.2024.12.002","article-title":"Establishing functionally segregated dopaminergic circuits","volume":"48","author":"Terauchi","year":"2025","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111475","article-title":"Advances in neurotransmitter-mediated prefrontal circuitry in depression","volume":"141","author":"Li","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib279","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/aps.2017.72","article-title":"Pharmacological modulation of the voltage-gated neuronal Kv7\/KCNQ\/M-channel alters the intrinsic excitability and synaptic responses of pyramidal neurons in rat prefrontal cortex slices","volume":"38","author":"Peng","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib280","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neuron.2020.02.030","article-title":"Muscarinic M1 receptors modulate working memory performance and activity via KCNQ potassium channels in the primate prefrontal cortex","volume":"106","author":"Galvin","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib281","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-008-1095-x","article-title":"A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels","volume":"199","author":"Fedorenko","year":"2008","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100153_bib282","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.029","article-title":"The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine","volume":"570","author":"Hansen","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib283","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2007.09.023","article-title":"Effect of the new antiepileptic drug retigabine in a rodent model of mania","volume":"12","author":"Dencker","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib284","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbr.2008.12.027","article-title":"Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania","volume":"198","author":"Redrobe","year":"2009","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib285","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/jpet.108.146944","article-title":"Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission","volume":"328","author":"Sotty","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib286","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2009.09.040","article-title":"Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder","volume":"207","author":"Dencker","year":"2010","journal-title":"Behav Brain Res"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100153_bib287","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2013.03.039","article-title":"Characterization of a novel high-potency positive modulator of Kv7 channels","volume":"709","author":"Dalby-Brown","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173440","article-title":"In vitro and in vivo characterization of Lu AA41178: a novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disorders","volume":"887","author":"Grupe","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137471","article-title":"Inhibition of neuronal Kv7 channels ameliorates MK-801-induced cognitive dysfunction in mice via up-regulating NAMPT expression","volume":"814","author":"Han","year":"2023","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib290","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1152\/jn.00270.2006","article-title":"Ethanol inhibition of M-current and ethanol-induced direct excitation of ventral tegmental area dopamine neurons","volume":"97","author":"Koyama","year":"2007","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib291","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/adb.12279","article-title":"Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption","volume":"21","author":"McGuier","year":"2016","journal-title":"Addict Biol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100153_bib292","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1016\/j.neuron.2024.07.018","article-title":"Molecular and circuit determinants in the globus pallidus mediating control of cocaine-induced behavioral plasticity","volume":"112","author":"Tian","year":"2024","journal-title":"Neuron"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100153_bib293","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1523\/JNEUROSCI.2767-17.2018","article-title":"Restoration of Kv7 channel-mediated inhibition reduces cued-reinstatement of cocaine seeking","volume":"38","author":"Parrilla-Carrero","year":"2018","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib294","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13428","article-title":"Kv7 channel opener retigabine reduces self-administration of cocaine but not sucrose in rats","volume":"29","author":"Urena","year":"2024","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib295","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"issue":"6181","key":"10.1016\/j.pharmr.2026.100153_bib296","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1126\/science.1249240","article-title":"Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience","volume":"344","author":"Friedman","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100153_bib297","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11671","article-title":"KCNQ channel openers reverse depressive symptoms via an active resilience mechanism","volume":"7","author":"Friedman","year":"2016","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100153_bib298","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.14026","article-title":"Selective targeting of M-type potassium Kv7.4 channels demonstrates their key role in the regulation of dopaminergic neuronal excitability and depression-like behaviour","volume":"174","author":"Li","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib299","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.neuron.2022.05.001","article-title":"Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2","volume":"110","author":"Lopez","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100153_bib300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173590","article-title":"Retigabine promotes ketamine\u2019s antidepressant effect in the forced swim test in male and female C57BL\/6J mice","volume":"230","author":"Qin","year":"2023","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib301","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41380-018-0283-2","article-title":"Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder","volume":"25","author":"Tan","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib302","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1176\/appi.ajp.2020.20050653","article-title":"Impact of the KCNQ2\/3 channel opener ezogabine on reward circuit activity and clinical symptoms in depression: results from a randomized controlled trial","volume":"178","author":"Costi","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib303","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1111\/epi.18056","article-title":"Progress report on new medications for seizures and epilepsy: a summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (Eilat XVII). I. Drugs in preclinical and early clinical development","volume":"65","author":"Bialer","year":"2024","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib304","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2025.02.897","article-title":"Effects of the KCNQ (Kv7) channel opener ezogabine on resting-state functional connectivity of striatal brain reward regions, depression, and anhedonia in major depressive disorder: results from a randomized controlled trial","volume":"98","author":"Chowdhury","year":"2025","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib305","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.apsb.2023.11.024","article-title":"A novel dual serotonin transporter and M-channel inhibitor D01 for antidepression and cognitive improvement","volume":"14","author":"Wei","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib306","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.083923","article-title":"Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels","volume":"314","author":"Korsgaard","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib307","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","article-title":"Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety","volume":"53","author":"Munro","year":"2007","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib308","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/1567202620666221025152325","article-title":"Chronic cerebral hypoperfusion-induced dysregulations of hyperpolarization- activated cyclic nucleotide-gated, KCNQ and G protein-coupled inwardly rectifying potassium channels correlated with susceptibility and unsusceptibility to anxiety behaviors","volume":"19","author":"Zhou","year":"2022","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib309","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41582-024-00932-4","article-title":"Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums","volume":"20","author":"Kamondi","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"S3","key":"10.1016\/j.pharmr.2026.100153_bib310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.33594\/000000397","article-title":"The amyloid precursor protein C99 fragment modulates voltage-gated potassium channels","volume":"55","author":"Manville","year":"2021","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib311","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134385","article-title":"Amyloid-\u03b2(25\u201335) modulates the expression of GirK and KCNQ channel genes in the hippocampus","volume":"10","author":"Mayordomo-Cava","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib312","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.neurobiolaging.2011.07.013","article-title":"Medial septal dysfunction by A\u03b2-induced KCNQ channel-block in glutamatergic neurons","volume":"33","author":"Le\u00e3o","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib313","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn1375","article-title":"Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior","volume":"8","author":"Peters","year":"2005","journal-title":"Nat Neurosci"},{"issue":"51","key":"10.1016\/j.pharmr.2026.100153_bib314","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021265118","article-title":"Spontaneous seizure and memory loss in mice expressing an epileptic encephalopathy variant in the calmodulin-binding domain of Kv7.2","volume":"118","author":"Kim","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100153_bib315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2014.09.009","article-title":"KCNQ\/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats","volume":"280","author":"Li","year":"2014","journal-title":"Neuroscience"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100153_bib316","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1113\/jphysiol.2010.192823","article-title":"Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter","volume":"588","author":"Zhong","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib317","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fphys.2015.00361","article-title":"H2S\u2212 and NO-signaling pathways in Alzheimer\u2019s amyloid vasculopathy: synergism or antagonism?","volume":"6","author":"Salmina","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib318","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib319","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1476-5381.1995.tb15019.x","article-title":"Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer","volume":"115","author":"Aiken","year":"1995","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-3565(24)37471-3","article-title":"Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine","volume":"285","author":"Zaczek","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib321","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.03.003","article-title":"Histamine induces KCNQ channel-dependent gamma oscillations in rat hippocampus via activation of the H1 receptor","volume":"118","author":"Andersson","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib322","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hipo.20717","article-title":"The M-current inhibitor XE991 decreases the stimulation threshold for long-term synaptic plasticity in healthy mice and in models of cognitive disease","volume":"21","author":"Font\u00e1n-Lozano","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmr.2026.100153_bib323","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pneurobio.2017.04.006","article-title":"Old and new challenges in Parkinson\u2019s disease therapeutics","volume":"156","author":"Pires","year":"2017","journal-title":"Prog Neurobiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib324","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1460-9568.2010.07107.x","article-title":"M-type channels selectively control bursting in rat dopaminergic neurons","volume":"31","author":"Drion","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib325","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-017-0177-3","article-title":"Potassium channels: a potential therapeutic target for Parkinson\u2019s disease","volume":"34","author":"Chen","year":"2018","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.pharmr.2026.100153_bib326","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/472676","article-title":"KV7 channels regulate firing during synaptic integration in GABAergic striatal neurons","volume":"2015","author":"P\u00e9rez-Ram\u00edrez","year":"2015","journal-title":"Neural Plast"},{"key":"10.1016\/j.pharmr.2026.100153_bib327","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainresbull.2017.11.011","article-title":"The Kv7\/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson\u2019s disease","volume":"137","author":"Liu","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmr.2026.100153_bib328","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110565","article-title":"Pharmacological and electrophysiological characterization of the novel Kv7 channel inhibitor racecadotril in Parkinson\u2019s disease","volume":"278","author":"Yang","year":"2025","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib329","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuropharm.2011.10.016","article-title":"Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates L-dopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"62","author":"Sander","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/ldw026","article-title":"Pathogenesis of amyotrophic lateral sclerosis","volume":"119","author":"Morgan","year":"2016","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pharmr.2026.100153_bib331","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2017.03.008","article-title":"Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis","volume":"292","author":"Maglemose","year":"2017","journal-title":"Exp Neurol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100153_bib332","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1113\/JP275906","article-title":"Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons","volume":"596","author":"Ghezzi","year":"2018","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib333","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41419-019-1538-9","article-title":"Dynamic interplay between H-current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis","volume":"10","author":"Buskila","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib334","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2014.03.019","article-title":"Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons","volume":"7","author":"Wainger","year":"2014","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib335","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41593-025-02096-w","article-title":"TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS\/FTD","volume":"28","author":"Joseph","year":"2025","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib336","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00319","article-title":"ICA-27243 improves neuromuscular function and preserves motoneurons in the transgenic SOD1G93A mice","volume":"21","author":"Masegosa","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib337","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamaneurol.2020.4300","article-title":"Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"78","author":"Wainger","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib338","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuropharm.2008.01.005","article-title":"Mechanisms of ischemic brain damage","volume":"55","author":"Doyle","year":"2008","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib339","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.24606","article-title":"Metabolic crisis occurs with seizures and periodic discharges after brain trauma","volume":"79","author":"Vespa","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmr.2026.100153_bib340","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2015.09.005","article-title":"Flupirtine effectively prevents development of acute neonatal seizures in an animal model of global hypoxia","volume":"607","author":"Sampath","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib341","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuropharm.2017.06.002","article-title":"Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy","volume":"123","author":"Sampath","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib342","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13311-023-01361-9","article-title":"Acute treatment with the M-channel (Kv7, KCNQ) opener retigabine reduces the long-term effects of repetitive blast traumatic brain injuries","volume":"20","author":"Vigil","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib343","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.0000217303.22856.38","article-title":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia","volume":"37","author":"Costa","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib344","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2006.03.024","article-title":"Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures","volume":"51","author":"Boscia","year":"2006","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100153_bib345","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1038\/sj.emboj.7601374","article-title":"Oxidative modification of M-type K+ channels as a mechanism of cytoprotective neuronal silencing","volume":"25","author":"Gamper","year":"2006","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100153_bib346","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/jcbfm.2015.83","article-title":"Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices","volume":"35","author":"Barrese","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib347","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1523\/JNEUROSCI.3805-14.2015","article-title":"Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury","volume":"35","author":"Bierbower","year":"2015","journal-title":"J Neurosci"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100153_bib348","first-page":"8509","article-title":"Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats","volume":"22","author":"Zhao","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib349","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s12975-025-01329-1","article-title":"Neuroprotective effects, mechanisms of action and therapeutic potential of the Kv7\/KCNQ channel opener QO-83 in ischemic stroke","volume":"16","author":"Zhang","year":"2025","journal-title":"Transl Stroke Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib350","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00004647-200104000-00008","article-title":"The Maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury","volume":"21","author":"Cheney","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100153_bib351","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/0271678X19857818","article-title":"Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, \u201cM-type\u201d) K+ currents in neurons","volume":"40","author":"Vigil","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib352","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1476-5381.2011.01273.x","article-title":"Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery","volume":"164","author":"Mani","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114931","article-title":"Kv7.4 channels regulate potassium permeability in neuronal mitochondria","volume":"197","author":"Paventi","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib354","doi-asserted-by":"crossref","first-page":"C893","DOI":"10.1152\/ajpcell.00709.2023","article-title":"Kv7 channel activation reduces brain endothelial cell permeability and prevents kainic acid-induced blood-brain barrier damage","volume":"326","author":"Celentano","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100153_bib355","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1002\/jcp.27889","article-title":"The dual role of KCNQ\/M channels upon OGD or OGD\/R insults in cultured cortical neurons of mice: timing is crucial in targeting M-channels against ischemic injur ies","volume":"234","author":"Diao","year":"2019","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib356","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2002.tb00233.x","article-title":"BMS-204352: a potassium channel opener developed for the treatment of stroke","volume":"8","author":"Jensen","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmr.2026.100153_bib357","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100153_bib358","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/jm034073f","article-title":"(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine","volume":"46","author":"Wu","year":"2003","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100153_bib359","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/jm034111v","volume":"46","author":"Wu","year":"2003","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100153_bib360","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm0305826","article-title":"Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers","volume":"47","author":"Wu","year":"2004","journal-title":"J Med Chem"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100153_bib361","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/03331024221114773","article-title":"The effects of certain TRP channels and voltage-gated KCNQ\/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system","volume":"42","author":"Citak","year":"2022","journal-title":"Cephalalgia"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100153_bib362","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.4275-12.2013","article-title":"Triple cysteine module within M-type K+ channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen species","volume":"33","author":"Ooi","year":"2013","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib363","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/ATVBAHA.114.303405","article-title":"Contribution of kv7.4\/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity","volume":"34","author":"Chadha","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100153_bib364","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng0297-186","article-title":"A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome","volume":"15","author":"Neyroud","year":"1997","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100153_bib365","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM199705293362204","article-title":"Molecular basis of the long-QT syndrome associated with deafness","volume":"336","author":"Splawski","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib366","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/hmg\/6.12.2179","article-title":"IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome","volume":"6","author":"Tyson","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"45","key":"10.1016\/j.pharmr.2026.100153_bib367","doi-asserted-by":"crossref","first-page":"34699","DOI":"10.1074\/jbc.M110.136192","article-title":"Kv7-type channel currents in spiral ganglion neurons: involvement in sensorineural hearing loss","volume":"285","author":"Lv","year":"2010","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100153_bib368","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/biomedicines10092254","article-title":"The pathological mechanisms of hearing loss caused by KCNQ1 and KCNQ4 variants","volume":"10","author":"Homma","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100153_bib369","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s12276-021-00653-4","article-title":"Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss","volume":"53","author":"Lee","year":"2021","journal-title":"Exp Mol Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib370","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1016\/j.ymthe.2025.08.049","article-title":"Engineered virus-like particles for in vivo gene editing ameliorate hearing loss in murine DFNA2 model","volume":"33","author":"Noh","year":"2025","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100153_bib371","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.ymthe.2025.08.044","article-title":"Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2","volume":"33","author":"Jang","year":"2025","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib372","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1152\/jn.01057.2009","article-title":"Effect of salicylate on KCNQ4 of the guinea pig outer hair cell","volume":"103","author":"Wu","year":"2010","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib373","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/mol.110.068130","article-title":"Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate","volume":"79","author":"Leitner","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"47","key":"10.1016\/j.pharmr.2026.100153_bib374","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.1515228112","article-title":"Unmyelinated type II afferent neurons report cochlear damage","volume":"112","author":"Liu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100153_bib375","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76754","article-title":"Repressor element 1-silencing transcription factor deficiency yields profound hearing loss through Kv7.4 channel upsurge in auditory neurons and hair cells","volume":"11","author":"Zhang","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100153_bib376","first-page":"44","article-title":"[General pharmacologic studies on the analgesic flupirtine]","volume":"35","author":"Jakovlev","year":"1985","journal-title":"Arzneim-Forsch"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib377","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00011-013-0592-5","article-title":"Flupirtine, a re-discovered drug, revisited","volume":"62","author":"Szelenyi","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib378","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0920-1211(95)00101-8","article-title":"D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures","volume":"233","author":"Rostock","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib379","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0026-895X(24)12060-3","article-title":"Modulation of KCNQ2\/3 potassium channels by the novel anticonvulsant retigabine","volume":"582","author":"Main","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(00)00866-1","article-title":"The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2\/3 subunits","volume":"2821","author":"Rundfeldt","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib381","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/mol.58.3.591","article-title":"Retigabine, a novel anti-convulsant, enhances activation of KCNQ2\/Q3 potassium channels","volume":"583","author":"Wickenden","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib382","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine","volume":"2115","author":"Tatulian","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib383","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1113\/jphysiol.2003.039842","article-title":"Effect of the KCNQ potassium channel opener retigabine on single KCNQ2\/3 channels expressed in CHO cells","volume":"549Pt 1","author":"Tatulian","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib384","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"533","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib385","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1476-5381.2011.01821.x","article-title":"Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine","volume":"1665","author":"Klinger","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib386","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.wnl.0000259034.45049.00","article-title":"Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures","volume":"6815","author":"Porter","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2026.100153_bib387","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1523\/JNEUROSCI.5176-14.2015","article-title":"Potent KCNQ2\/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus","volume":"3523","author":"Kalappa","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib388","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.115.103200","article-title":"Synthesis and evaluation of potent KCNQ2\/3-specific channel activators","volume":"896","author":"Kumar","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib389","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/acs.jmedchem.2c00911","article-title":"Beyond retigabine: design, synthesis, and pharmacological characterization of a potent and chemically stable neuronal Kv7 channel activator with anticonvulsant activity","volume":"6516","author":"Musella","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib390","doi-asserted-by":"crossref","DOI":"10.1201\/9781003459361","article-title":"A novel compound QO-83 alleviates acute and chronic epileptic seizures in rodents by modulating KV7 channel activity","volume":"313","author":"Wang","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib391","doi-asserted-by":"crossref","first-page":"117381","DOI":"10.1016\/j.bcp.2025.117381","article-title":"In Vivo\/In vitro metabolic profiling and evaluation of key metabolites of QO-83, a novel KCNQ channel opener with antiepileptic potential","volume":"242Pt 3","author":"Yang","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib392","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/acs.jmedchem.9b00796","article-title":"Synthesis and pharmacological characterization of conformationally restricted retigabine analogues as novel neuronal Kv7 channel activators","volume":"631","author":"Ostacolo","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib393","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mol.114.095190","article-title":"P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity","volume":"871","author":"Zhou","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib394","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/acsmedchemlett.8b00315","article-title":"Discovery of novel retigabine derivatives as potent KCNQ4 and KCNQ5 channel agonists with improved specificity","volume":"101","author":"Wang","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib395","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/epi.18092","article-title":"Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity","volume":"6510","author":"Wang","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib396","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.bmcl.2004.01.069","article-title":"(S)-N-[1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide is a potent and efficacious KCNQ2 opener which inhibits induced hyperexcitability of rat hippocampal neurons","volume":"148","author":"Wu","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib397","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuropharm.2006.07.001","article-title":"The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels","volume":"516","author":"Bentzen","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2026.100153_bib398","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1016\/j.bmcl.2004.06.035","article-title":"Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides","volume":"1417","author":"Wu","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib399","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1016\/j.bmcl.2013.08.092","article-title":"Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain","volume":"2322","author":"Wu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib400","article-title":"From pan-reactive KV7 channel opener to subtype selective opener\/inhibitor by addition of a methyl group","volume":"96","author":"Blom","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100153_bib401","doi-asserted-by":"crossref","first-page":"28322","DOI":"10.1074\/jbc.M110.116392","article-title":"Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions","volume":"28536","author":"Gao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib402","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/cr.2013.82","article-title":"The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands","volume":"239","author":"Li","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib403","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/mol.107.043216","article-title":"N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2\/Q3 potassium channel activator","volume":"733","author":"Wickenden","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib404","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/ml200053x","article-title":"N-Pyridyl and Pyrimidine Benzamides as KCNQ2\/Q3 Potassium Channel Openers for the Treatment of Epilepsy","volume":"26","author":"Amato","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib405","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/mol.114.093799","article-title":"Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4\/7.5 channels by ML213 and ICA-069673","volume":"863","author":"Brueggemann","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib406","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/bph.12065","article-title":"The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential","volume":"1685","author":"Boehlen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib407","doi-asserted-by":"crossref","DOI":"10.15302\/vita.2026.05.0035","article-title":"Structural basis for the assembly and modulation of human M-channels","author":"Lu","year":"2026","journal-title":"Vita"},{"key":"10.1016\/j.pharmr.2026.100153_bib408","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/mol.104.007112","article-title":"Meclofenamic acid and diclofenac, novel templates of KCNQ2\/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties","volume":"674","author":"Peretz","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib409","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/mol.110.067496","article-title":"Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits","volume":"791","author":"Brueggemann","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib410","article-title":"A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives","volume":"212","author":"Peretz","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100153_bib411","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/jn.00634.2006","article-title":"Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release","volume":"971","author":"Peretz","year":"2007","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib412","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.bmcl.2015.04.074","article-title":"Discovery of a novel Kv7 channel opener as a treatment for epilepsy","volume":"2521","author":"Davoren","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib413","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.bmcl.2018.04.040","article-title":"Design, synthesis and evaluation of substituted piperidine based KCNQ openers as novel antiepileptic agents","volume":"2810","author":"Yang","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib414","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1016\/j.bmcl.2018.05.019","article-title":"Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy","volume":"2817","author":"Yang","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2026.100153_bib415","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1096\/fj.201802848RR","article-title":"Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy","volume":"338","author":"Zhang","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100153_bib416","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(02)01287-6","article-title":"Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352","volume":"4373","author":"Dupuis","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib417","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0028-3908(01)00029-6","article-title":"KCNQ4 channel activation by BMS-204352 and retigabine","volume":"407","author":"Schr\u00f8der","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2026.100153_bib418","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/cn200065b","article-title":"Synthesis, and structure activity relationship of a series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: characterization of ML213 as a novel KCNQ2 and KCNQ4 potassium channel opener","volume":"210","author":"Yu","year":"2011","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib419","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1476-5381.2012.02232.x","article-title":"Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58","volume":"1684","author":"Zhang","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib420","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1124\/jpet.114.217703","article-title":"The human ether-a-go-go\u2013related gene activator NS1643 enhances epilepsy-associated KCNQ channels","volume":"3513","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib421","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/aps.2015.142","article-title":"Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques","volume":"371","author":"Yue","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmr.2026.100153_bib422","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"922","author":"Bialer","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib423","doi-asserted-by":"crossref","first-page":"108884","DOI":"10.1016\/j.neuropharm.2021.108884","article-title":"The novel dual-mechanism Kv7 potassium channel\/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model","volume":"203","author":"Bloms-Funke","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2026.100153_bib424","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00197","article-title":"Novel dual mechanism GRT-X agonist acting on Kv7 potassium channel\/translocator protein receptor prevents motoneuron degeneration following exposure to mouse and human amyotrophic lateral sclerosis\/frontotemporal dementia astrocyte-conditioned media","author":"Masegosa","year":"2025","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib425","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/j.pain.0000000000003390","article-title":"Dual Kv7.2\/3-TRPV1 modulators inhibit nociceptor hyperexcitability and alleviate pain without target-related side effects","volume":"1664","author":"Raveh","year":"2025","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib426","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c00945","article-title":"Discovery and in-vivo characterization of Kv7 channel openers through a phenotypic approach","author":"Siegrist","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib427","doi-asserted-by":"crossref","first-page":"110658","DOI":"10.1016\/j.neuropharm.2025.110658","article-title":"IDOR-1104-0086, a novel Kv7 channel activator with antiseizure effects in rodents","volume":"280","author":"Kessler","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2026.100153_bib428","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nchembio874","article-title":"Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants","volume":"35","author":"Xiong","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100153_bib429","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/jpet.119.258053","article-title":"Implication of Kv7 channels in the spinal antinociceptive actions of celecoxib","volume":"370","author":"Vicente-Baz","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100153_bib430","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/j.pain.0000000000001474","article-title":"The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels","volume":"160","author":"Ray","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.pharmr.2026.100153_bib431","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/ATVBAHA.120.313997","article-title":"Acetaminophen (paracetamol) metabolites induce vasodilation and hypotension by activating Kv7 potassium channels directly and indirectly","volume":"405","author":"van der Horst","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmr.2026.100153_bib432","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1111\/bph.13639","article-title":"Selective activation of vascular Kv 7.4\/Kv 7.5 K+ channels by fasudil contributes to its vasorelaxant effect","volume":"17324","author":"Zhang","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib433","article-title":"Cannabidiol activates neuronal Kv7 channels","volume":"11","author":"Zhang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.pharmr.2026.100153_bib434","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1111\/bph.16183","article-title":"Subtype-specific modulation of human KV 7 channels by the anticonvulsant cannabidiol through a lipid-exposed pore-domain site","volume":"18023","author":"P\u00f6kl","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib435","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70119","article-title":"The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: potential repurposing for epilepsy treatment","author":"Carotenuto","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib436","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1124\/mol.118.112953","article-title":"Gabapentin Is a potent activator of KCNQ3 and KCNQ5 potassium channels","volume":"944","author":"Manville","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib437","doi-asserted-by":"crossref","first-page":"105200","DOI":"10.1016\/j.phrs.2020.105200","article-title":"Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy","volume":"160","author":"Soldovieri","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2026.100153_bib438","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41467-018-06339-2","article-title":"Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket","volume":"91","author":"Manville","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100153_bib439","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1096\/fj.201900485R","article-title":"Cilantro leaf harbors a potent potassium channel\u2013activating anticonvulsant","volume":"3310","author":"Manville","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100153_bib440","doi-asserted-by":"crossref","first-page":"21236","DOI":"10.1073\/pnas.1907511116","article-title":"KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines","volume":"11642","author":"Manville","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100153_bib441","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s42003-020-1089-8","article-title":"The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator","volume":"31","author":"Redford","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.pharmr.2026.100153_bib442","article-title":"Medicinal plant rosemary relaxes blood vessels by activating vascular smooth muscle KCNQ channels","volume":"379","author":"Manville","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100153_bib443","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s42003-023-05021-8","article-title":"Ancient medicinal plant rosemary contains a highly efficacious and isoform-selective KCNQ potassium channel opener","volume":"61","author":"Manville","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.pharmr.2026.100153_bib444","article-title":"A drug pocket at the lipid bilayer-potassium channel interface","volume":"310","author":"Ottosson","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2026.100153_bib445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0091-3057(93)90278-2","article-title":"Linopirdine (DuP996) facilitates the retention of avoidance training and improves performance of septal-lesioned rats in the water maze","volume":"441","author":"Brioni","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2026.100153_bib446","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S031716710002148X","article-title":"A randomized, controlled trial of linopirdine in the treatment of Alzheimer\u2019s disease","volume":"242","author":"Rockwood","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pharmr.2026.100153_bib447","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0026-895X(24)23232-6","article-title":"Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991","volume":"576","author":"Wang","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib448","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00116-4","article-title":"KCNQ potassium channels: physiology, pathophysiology, and pharmacology","volume":"901","author":"Robbins","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib449","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/mol.110.066100","article-title":"The specific slow afterhyperpolarization inhibitor UCL2077 is a subtype-selective blocker of the epilepsy associated KCNQ channels","volume":"786","author":"Soh","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib450","series-title":"Probe Reports from the NIH Molecular Libraries Program","article-title":"Identification of a novel, small molecule inhibitor of KCNQ2 channels","author":"Yu","year":"2010"},{"key":"10.1016\/j.pharmr.2026.100153_bib451","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1021\/jm300700v","volume":"5515","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib452","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/aps.2013.79","article-title":"Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels","volume":"3410","author":"Hu","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmr.2026.100153_bib453","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1096\/fj.14-250647","article-title":"Promiscuous gating modifiers target the voltage sensor of Kv7.2, TRPV1, and Hv1 cation channels","volume":"286","author":"Kornilov","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2026.100153_bib454","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/molpharm.122.000640","article-title":"Modulation of Kv7 channel currents by echinocystic acid","volume":"1042","author":"Geng","year":"2023","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib456","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1021\/jm00045a005","article-title":"Synthesis and quantitative structure-activity relationships of anticonvulsant 2,3,6-triaminopyridines","volume":"3719","author":"Seydel","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib457","article-title":"Retigabine, a Kv7.2\/Kv7.3-channel opener, attenuates drug-induced seizures in knock-in mice harboring Kcnq2 mutations","volume":"112","author":"Ihara","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100153_bib458","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1111\/bph.13262","article-title":"\u03b4 Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine","volume":"17220","author":"Klinger","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib459","first-page":"1063","article-title":"Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels","volume":"5012","author":"Rundfeldt","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pharmr.2026.100153_bib460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(03)01426-2","article-title":"Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex","volume":"4642","author":"van Rijn","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib461","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acs.chemrestox.8b00313","article-title":"An investigation into retigabine (ezogabine) associated dyspigmentation in rat eyes by MALDI imaging mass spectrometry","volume":"322","author":"Groseclose","year":"2019","journal-title":"Chem Res Toxicol"},{"issue":"Pt 1","key":"10.1016\/j.pharmr.2026.100153_bib462","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1097\/01.ju.0000138155.33749.f4","article-title":"Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats","volume":"1725","author":"Streng","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.pharmr.2026.100153_bib463","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1113\/JP277021","article-title":"The KV7 channel activator retigabine suppresses mouse urinary bladder afferent nerve activity without affecting detrusor smooth muscle K+ channel currents","volume":"5973","author":"Tykocki","year":"2019","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib464","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2010.03.050","article-title":"Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder","volume":"6381","author":"Rode","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib465","first-page":"225","article-title":"Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine","volume":"2","author":"Barrese","year":"2010","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib466","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/acs.jmedchem.0c02252","article-title":"Discovery of HN37 as a potent and chemically stable antiepileptic drug candidate","volume":"649","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib467","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.108.137794","article-title":"In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2\/Q3 (Kv7.2\/Kv7.3) activator in rodent anticonvulsant models","volume":"3263","author":"Roeloffs","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib468","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/JP272762","article-title":"Sequence determinants of subtype-specific actions of KCNQ channel openers","volume":"5953","author":"Wang","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib469","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1085\/jgp.201812014","article-title":"Four drug-sensitive subunits are required for maximal effect of a voltage sensor\u2013targeted KCNQ opener","volume":"15010","author":"Wang","year":"2018","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib470","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1085\/jgp.201812013","article-title":"One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels","volume":"15010","author":"Yau","year":"2018","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib471","doi-asserted-by":"crossref","first-page":"1138556","DOI":"10.3389\/fphar.2023.1138556","article-title":"Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability","volume":"14","author":"Estacion","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib472","doi-asserted-by":"crossref","first-page":"15637","DOI":"10.1073\/pnas.0911294107","article-title":"Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier","volume":"10735","author":"Peretz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100153_bib473","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16592","article-title":"Functional and behavioral signatures of Kv7 activator drug subtypes","volume":"618","author":"Kanyo","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib474","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/epi.12224","article-title":"Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy","volume":"548","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib475","article-title":"Phase I study of PF-04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis","volume":"71","author":"Aleo","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.pharmr.2026.100153_bib476","article-title":"Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicity","volume":"76","author":"Generaux","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.pharmr.2026.100153_bib477","doi-asserted-by":"crossref","first-page":"174935","DOI":"10.1016\/j.ejphar.2022.174935","article-title":"A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration","volume":"923","author":"Bloms-Funke","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib478","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00406-022-01532-3","article-title":"Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options","volume":"2737","author":"Rupprecht","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib479","doi-asserted-by":"crossref","first-page":"102634","DOI":"10.1016\/j.pneurobio.2024.102634","article-title":"TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates","volume":"240","author":"Soca\u0142a","year":"2024","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib480","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2007.11.010","article-title":"Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds","volume":"292","author":"Xiong","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2026.100153_bib481","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"18514","author":"Patrignani","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2026.100153_bib482","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of celecoxib","volume":"383","author":"Davies","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2026.100153_bib483","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/bph.16380","article-title":"A triple cysteine motif as major determinant of the modulation of neuronal KV7 channels by the paracetamol metabolite N-acetyl-p-benzo quinone imine","volume":"18116","author":"Ray","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib484","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41380-023-02218-5","article-title":"Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice","volume":"2812","author":"Liu","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100153_bib485","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WCO.0000000000000660","article-title":"Cannabinoid therapy in epilepsy","volume":"322","author":"Billakota","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pharmr.2026.100153_bib486","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"29343","author":"Ghovanloo","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100153_bib487","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58593","article-title":"Cannabidiol interactions with voltage-gated sodium channels","volume":"9","author":"Sait","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.pharmr.2026.100153_bib488","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.111.190702","article-title":"Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia","volume":"3421","author":"Langlois","year":"2012","journal-title":"J Pharmacol\u2216 Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib489","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","article-title":"Calcium channel \u03b12\u03b4 subunits in epilepsy and as targets for antiepileptic drugs","author":"Dolphin","year":"2012"},{"key":"10.1016\/j.pharmr.2026.100153_bib490","doi-asserted-by":"crossref","first-page":"46","DOI":"10.33594\/000000337","article-title":"KCNQ5 potassium channel activation underlies vasodilation by tea","volume":"55","author":"Redford","year":"2021","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmr.2026.100153_bib491","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1085\/jgp.201711965","article-title":"Atom-by-atom tuning of the electrostatic potassium-channel modulator dehydroabietic acid","volume":"1505","author":"Silver\u00e5 Ejneby","year":"2018","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.pharmr.2026.100153_bib492","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/epi.16932","article-title":"Synthetic resin acid derivatives selectively open the hKV 7.2\/7.3 channel and prevent epileptic seizures","volume":"627","author":"Ottosson","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib493","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0128-05.2005","article-title":"Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine","volume":"2520","author":"Schenzer","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100153_bib494","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/mol.104.010793","article-title":"The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate","volume":"674","author":"Wuttke","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100153_bib495","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/epi.14557","article-title":"Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development","volume":"5910","author":"Bialer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib496","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/epi.17376","article-title":"Progress report on new antiepileptic drugs: a summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development","volume":"6311","author":"Bialer","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmr.2026.100153_bib497","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/epi.16725","article-title":"Progress report on new antiepileptic drugs: a summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development","volume":"6111","author":"Bialer","year":"2020","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100153_bib498","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.14278","article-title":"Azetukalner, a novel KV7 potassium channel opener, in adults with major depressive disorder: a randomized clinical trial","volume":"8","author":"Butterfield","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pharmr.2026.100153_bib499","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-024-01155-3","article-title":"Targeting Kv7 potassium channels for epilepsy","author":"Perucca","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmr.2026.100153_bib500","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41401-023-01073-y","article-title":"Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy","volume":"448","author":"Yang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmr.2026.100153_bib501","article-title":"A randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of multiple oral doses of Pynegabine tablets as add-on therapy in patients with focal epilepsy","volume":"309","author":"Wei","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pharmr.2026.100153_bib502","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.05.029","article-title":"Gene therapy and editing: novel potential treatments for neuronal channelopathies","volume":"132","author":"Wykes","year":"2018","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:46:25Z","timestamp":1790041585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":500,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0031699726000414"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100153","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kv7 channels as pharmacological targets for central nervous system diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100153"}}